tiprankstipranks
Argenx price target raised to $660 from $540 at Truist
The Fly

Argenx price target raised to $660 from $540 at Truist

Truist raised the firm’s price target on Argenx (ARGX) to $660 from $540 and keeps a Buy rating on the shares after its Q3 earnings beat. The company delivered 11th consecutive sequential growth quarter and the stock offers the most enviable I&I – inflammation and immunology – pipeline in the industry, with multiple data read-outs over the next 12-18 months, the analyst tells investors in a research note.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App